Home > Healthcare > Cell Therapy Technologies Market
Cell Therapy Technologies Market Size
Cell Therapy Technologies Market size is projected to expand at substantial pace from 2024 to 2032. The utilization of cell therapy technologies in clinical research for HIV/AIDS, cancer, and other contagious diseases, along with their application in providing diagnostic and prognostic information is driving the industry gains. According to WHO estimates, 39 million people worldwide were living with HIV at the end of 2022. Population growth, climate change, and heightened human-animal interaction are also elevating the risk of new viral outbreaks and increasing the adoption of cell therapy treatments.
The integration of automation and robotics into manufacturing processes is driving the adoption of cell therapy technology and enhancing efficiency, scalability, and reproducibility while reducing the risk of contamination. The notable surge in closed system bioprocessing technologies is helping address the critical challenges in cell therapy manufacturing by improving sterility and safety through minimal human intervention. However, the high costs of therapy development, manufacturing complexities, regulatory challenges, and limited reimbursement policies may restrain the industry development to a certain extent.
Cell Therapy Technologies Market Trends
The use of advanced analytical tools for quality control and process optimization will escalate the technology demand. Integration of novel assays, imaging technologies, and data analytics are facilitating real-time monitoring and characterization of cellular products for ensuring higher efficacy and safety profiles. The rising focus on developing innovative biomaterials and scaffolds to enhance cell delivery and engraftment in vivo is increasing the appeal of cell therapy technologies. These materials offer improved biocompatibility, controlled release kinetics, and better retention at the target site, further augmenting the therapeutic potential of cell-based therapies. The regulatory advancements and increasing collaborations between industry stakeholders and research institutions are also fostering innovations and accelerating the translation of cell therapy technologies from bench to bedside.
Cell Therapy Technologies Market Analysis
The market value from the T-cell segment is anticipated to rise at significant pace between 2024 and 2032, owing to the rising need for better therapeutic approaches for diseases, such as cancer and cardiovascular diseases (CVDs). The increasing prevalence of cancer and autoimmune diseases is creating high demand for T-cell immunotherapies. The advancements in genetic engineering techniques like CAR-T cell therapy are enhancing the efficacy and specificity of T-cell therapies. Ongoing research and clinical trials for exploring new applications of T-cell therapies will also push the segment expansion.
Cell therapy technologies market value from the cell bank and research institutes end-use segment is estimated to witness commendable progress through 2032. This is due to the high investments in stem cell research and regenerative medicine by academic and research institutions. Collaborations between research institutes and biotechnology companies are promoting the development of novel cell therapies. The growing focus on personalized medicine and the need for robust cell repositories will further boost the segment progression.
North America cell therapy technologies market is expected to witness substantial CAGR from 2024 to 2032, on account of the rising prevalence of chronic diseases like cancer and autoimmune disorders, subsequently creating a high demand for innovative cell therapies. As per the American Cancer Society, the U.S. is estimated to witness around 62,770 new cases of leukemia in 2024. The supportive regulatory frameworks and favorable reimbursement policies are facilitating the adoption of advanced cell therapy technologies. The robust healthcare infrastructure, significant R&D investments and the strong presence of key market players.
<Cell Therapy Technologies Market Share
Some of the major cell therapy technology companies are:
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Danaher Corporation
- Sartorius AG
- FUJIFILM Irvine Scientific, Inc.
- Lonza Group AG
- Becton Dickinson and Company
- GE Healthcare
- Terumo BCT
- Avantor Inc.
- Bio-Techne Corporation
- Corning Incorporated.
Leading firms working in the cell therapy technologies industry are engaging in business expansion strategies, such as mergers & acquisitions, partnerships and launching novel solutions in the market to increase their foothold.
Cell Therapy Technologies Industry News:
- In March 2023, Danaher Corporation initiated a strategic collaboration with the University of Pennsylvania to address manufacturing challenges affecting the uptake of cellular immunotherapies.
What Information does this report contain?
Frequently Asked Questions (FAQ) :